Showing 1 - 10 of 66
Drug Policy of 1986
Persistent link: https://www.econbiz.de/10009323735
€™, caregivers’, or health care providers’ perceptions of adherence to preventive or curative TB treatment with the free text … recent years, particularly in low- and middle-income countries where it is closely associated with HIV/AIDS. Poor adherence … holistic understanding of barriers to and facilitators of, treatment adherence is currently a major obstacle to finding …
Persistent link: https://www.econbiz.de/10005487832
This report analyzes the ITRIPS agreement. It discuses the problems and stakes, and consequences of this agreement. The report also provides case studies related to the topic and finally gives a suggestive conclusion.
Persistent link: https://www.econbiz.de/10005528311
This paper seeks to evaluate quantity and quality of service delivery in rural public health facilities under NRHM. On appropriate and feasible measures, the former is assessed on the static and dynamic condition of physical infrastructure; by the numbers of paramedical, technician and medical...
Persistent link: https://www.econbiz.de/10004998008
The Doha Declaration provides for access to medicines particularly by simplifying the compulsory licensing (CL) clause …
Persistent link: https://www.econbiz.de/10004987323
India has a booming drug industry and has contributed to making generics at low prices worldwide. But medicines within … India are overpriced and unaffordable. Price regulation of medicines is a key public policy measure for health of Indiaâ …
Persistent link: https://www.econbiz.de/10004988801
This paper details the procedures adopted by the Tamil Nadu Medical Services Corporation in procuring and supplying essential drugs to the government health care which is a positive measure in ensuring `health for all’. [GIDR WP No. 161].
Persistent link: https://www.econbiz.de/10004990961
Modifications to Drug Policy 1986
Persistent link: https://www.econbiz.de/10009250151
Pharmaceutical Policy of 2002 covering issues of pricing, ,marketing, size of market, quality, production, investment, regulatory authority, monitoring, ethical issues
Persistent link: https://www.econbiz.de/10009250530
Poor quality essential medicines, both substandard and counterfeit, are serious but neglected public health problems …. Anti-infective medicines are particularly afflicted. Unfortunately, attempts to improve medicine quality have been hampered … by confusion and controversy over definitions. For counterfeit (or falsified) medicines, this has arisen from perceived …
Persistent link: https://www.econbiz.de/10009393988